FDA
-
-
-
-
-
-
-
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
-
-
-
-
-
-
-
Biobeat Technologies Names Raymond W. Cohen as Chairman of the Board of Directors
-
-
-
-
-
-
-
InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke
-
-
-
-
-
-
-
InspireMD (NSPR) Announces CFO Change
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on InspireMD (NSPR)
-
-
-
-
-
-
-
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
InspireMD (NSPR) Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. IDE Clinical Trial at VIVA23
-
322,969 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

